Search for: "Nicholson Price" Results 101 - 120 of 139
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Texas Outfitters v. Nicholson and the Duty of the Holder of the Executive Right
18 Apr 2019, 7:35 am by John McFarland
Nicholson, No. 17-0509, once again addressing the duty of the holder of executive rights to minerals [read post]
Oil and Gas Lawyer Blog - http://www.oilandgaslawyerblog.com/
IPSC Opening Plenary Session
3 Aug 2023, 8:15 am by Rebecca Tushnet
Nicholson Price, Empirical Studies of Medical AI Patents (w/ Mateo Aboy & Seth Raker) Applications [read post]
43(B)log - http://tushnet.blogspot.com/
How are COVID-19 vaccine manufacturers aiming to encourage trust in the FDA’s approval process?
2 Oct 2020, 7:10 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn recent weeks, a number of articles have reported [read post]
Written Description - http://writtendescription.blogspot.com/
How should policymakers incentivize and regulate convalescent serum therapy for COVID-19?
22 Jul 2020, 12:12 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsOver 120 years ago, a milk wagon [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers encourage the expansion of at-home diagnostic testing for COVID-19?
2 Jun 2020, 10:31 pm by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What’s happening with proposals for a WTO waiver of COVID-related IP?
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can policymakers encourage COVID-19 vaccine trials for children?
18 Dec 2020, 6:37 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsThe past two weeks have been full [read post]
Written Description - http://writtendescription.blogspot.com/
Are COVID-19 vaccine advance purchases a form of vaccine nationalism, an effective spur to innovation, or something in between?
5 Aug 2020, 11:43 am by Lisa Larrimore Ouellette
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
#IPSC18 Preview: Patents & Innovation
30 Jul 2018, 10:44 am by Lisa Ouellette
(Related to literature on basing damages on R&D costs, which I review here.)Nicholson Price  [read post]
Written Description - http://writtendescription.blogspot.com/
Soccer Technology: Too Much Innovation?
9 Jun 2010, 7:02 am by Mike Madison
which co-brands the “official” ball) and adidas, which sells copies of the ball at various price [read post]
madisonian.net - http://madisonian.net
What are the challenges in developing information around mixing-and-matching COVID-19 vaccines and therapies?
21 Jan 2022, 8:35 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several [read post]
Written Description - http://writtendescription.blogspot.com/
How can health regulators maintain public trust when facing scientific uncertainty?
24 Jun 2020, 5:36 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How can innovation and regulatory policy accomplish robust COVID-19 testing?
15 Apr 2020, 8:14 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowIt’s now clear that [read post]
Written Description - http://writtendescription.blogspot.com/
Why do differences in clinical trial design make it hard to compare COVID-19 vaccines?
30 Jun 2021, 10:31 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How are COVID-19 vaccine developers and regulators responding to variants?
25 Mar 2021, 1:24 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
What can policymakers learn from the disastrously slow COVID-19 vaccine rollout?
12 Jan 2021, 9:04 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
How will the FDA’s new COVID-19 vaccine guidance affect development efforts?
10 Jul 2020, 8:59 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PricePolicymakers are expectantly awaiting the development [read post]
Written Description - http://writtendescription.blogspot.com/
Selikoff and the Mystery of the Disappearing Amphiboles
10 Dec 2010, 1:09 pm by Schachtman
Berry, “Sixty years on: the price of assembling military gas masks in 1940,” 63 Occupational [read post]
Tortini - http://schachtmanlaw.com/blog/
Molnupiravir may become the first COVID-19 pill. What took so long?
5 Nov 2021, 8:20 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Written Description - http://writtendescription.blogspot.com/